NU-9 halts Alzheimer’s disease in animal model before symptoms begin
Peer-Reviewed Publication
Updates every hour. Last Updated: 18-Dec-2025 10:12 ET (18-Dec-2025 15:12 GMT/UTC)
Experimental drug NU-9 shows promise in clearing toxic proteins associated with neurodegenerative diseases. Scientists tested NU-9 in a pre-symptomatic animal model of Alzheimer’s disease. Drug dramatically reduced brain changes that emerge near the disease’s onset. Researchers have hope that NU-9 could act as a potential prophylaxis to prevent Alzheimer's symptoms from appearing.
A team of researchers, led by Lisa Marsch, PhD, at Dartmouth’s Geisel School of Medicine, has received a four-year $13-million grant from the National Institute on Drug Abuse (NIDA) to conduct the first-ever multisite clinical trial evaluating long-acting medication in the treatment of opioid use disorder among adolescents.